Dokic Yelena, Nguyen Quynh-Giao Ly, Orengo Ida
Department of Dermatology, Baylor College of Medicine, Houston, TX.
Dermatol Online J. 2020 Apr 15;26(4):13030/qt8zr4f9n4.
Mohs micrographic surgery (MMS) is a breakthrough surgical technique that has changed the management of neoplasms in dermatology. Through continued practice and evolution, MMS now can successfully treat a variety of rare non-melanocytic cutaneous malignancies for which achieving remission and the optimal aesthetic result after surgery was previously challenging. Mohs micrographic surgery has utility for conditions besides melanoma. Herein, we discuss this versatility of Mohs micrographic surgery. Specifically, Mohs micrographic surgery can be successfully used for cases such as dermatofibrosarcoma protuberans, atypical fibroxanthomas, extramammary Paget disease, Merkel cell carcinoma, sebaceous carcinoma, and microcystic adnexal carcinoma.
莫氏显微外科手术（MMS）是一项突破性的外科技术，它改变了皮肤科肿瘤的治疗方式。通过持续的实践和发展，MMS现在能够成功治疗多种罕见的非黑素细胞性皮肤恶性肿瘤，而此前要实现缓解以及术后达到最佳美学效果颇具挑战。莫氏显微外科手术除了对黑色素瘤有效外，还有其他用途。在此，我们将探讨莫氏显微外科手术的这种多功能性。具体而言，莫氏显微外科手术可成功用于治疗诸如隆突性皮肤纤维肉瘤、非典型纤维黄色瘤、乳房外佩吉特病、默克尔细胞癌、皮脂腺癌和微囊性附属器癌等病例。
